Paper I
2019 February (2010 Scheme) · 40 marks · 120 min

Question

HMG-CoA reductase inhibitor

Q160.3 marksShort Answers

Answer

Atorvastatin — inhibits HMG-CoA reductase, the rate-limiting enzyme in hepatic cholesterol synthesis, reducing LDL cholesterol production and upregulating hepatic LDL receptors (increasing LDL clearance from plasma), making it effective for hyperlipidaemia and cardiovascular risk reduction.

Other Years Asked


Revise MBBS
Preview